{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:59:31Z","timestamp":1793642371653,"version":"4.5.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cca.2021.10.018","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T12:29:15Z","timestamp":1634819355000},"page":"374-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases"],"prefix":"10.1016","volume":"523","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5591-9100","authenticated-orcid":false,"given":"H\u00fcseyin","family":"Vural","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferah","family":"Armutcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Akyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cca.2021.10.018_b0005","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin. Proc."},{"issue":"7","key":"10.1016\/j.cca.2021.10.018_b0010","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International consensus panel. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1 Suppl","key":"10.1016\/j.cca.2021.10.018_b0015","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.cca.2021.10.018_b0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4093\/dmj.2019.0011","article-title":"Nonalcoholic fatty liver disease in diabetes. Part I: Epidemiology and diagnosis","volume":"43","author":"Lee","year":"2019","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.cca.2021.10.018_b0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/B978-0-12-407680-8.00004-X","article-title":"Markers in nonalcoholic steatohepatitis","volume":"61","author":"Armutcu","year":"2013","journal-title":"Adv. Clin. Chem."},{"issue":"4","key":"10.1016\/j.cca.2021.10.018_b0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1179\/1351000213Y.0000000050","article-title":"The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis","volume":"18","author":"Ucar","year":"2013","journal-title":"Redox Rep."},{"issue":"4","key":"10.1016\/j.cca.2021.10.018_b0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tcm.2016.11.002","article-title":"The role of electronegative low-density lipoprotein in cardiovascular diseases and its therapeutic implications","volume":"27","author":"Akyol","year":"2017","journal-title":"Trends Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.cca.2021.10.018_b0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/CIRCRESAHA.108.190116","article-title":"Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis","volume":"104","author":"Lu","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2021.10.018_b0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jnutbio.2015.11.019","article-title":"Electronegative LDL is linked to high-fat, high-cholesterol diet-induced nonalcoholic steatohepatitis in hamsters","volume":"30","author":"Lai","year":"2016","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.cca.2021.10.018_b0050","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-16-0513","article-title":"Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones","volume":"234","author":"Geisler","year":"2017","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.cca.2021.10.018_b0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","author":"Dowman","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.cca.2021.10.018_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/783976","article-title":"Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation","volume":"2011","author":"Fon Tacer","year":"2011","journal-title":"J Lipids."},{"issue":"04","key":"10.1016\/j.cca.2021.10.018_b0065","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0033-1358519","article-title":"Lipoprotein Metabolism, Dyslipidemia and Nonalcoholic Fatty Liver Disease","volume":"33","author":"Cohen","year":"2013","journal-title":"Semin. Liver Dis."},{"issue":"30","key":"10.1016\/j.cca.2021.10.018_b0070","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cca.2021.10.018_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7555\/JBR.27.20120077","article-title":"Lipoprotein metabolism in nonalcoholic fatty liver disease","volume":"27","author":"Jiang","year":"2013","journal-title":"J. Biomed. Res."},{"issue":"8","key":"10.1016\/j.cca.2021.10.018_b0080","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4254\/wjh.v12.i8.436","article-title":"Lipidomics in non-alcoholic fatty liver disease","volume":"12","author":"Kartsoli","year":"2020","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.cca.2021.10.018_b0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jmcb\/mjw016","article-title":"Discovering a critical transition state from nonalcoholic hepatosteatosis to nonalcoholic steatohepatitis by lipidomics and dynamical network biomarkers","volume":"8","author":"Sa","year":"2016","journal-title":"J. Mol. Cell. Biol."},{"key":"10.1016\/j.cca.2021.10.018_b0090","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cca.2021.10.018_b0095","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1038\/nutd.2016.27","article-title":"Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects","volume":"6","author":"Ma","year":"2016","journal-title":"Nutr. Diabetes"},{"issue":"5","key":"10.1016\/j.cca.2021.10.018_b0100","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/nu10050649","article-title":"Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors","volume":"10","author":"Tiwari-Heckler","year":"2018","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.cca.2021.10.018_b0105","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2021.10.018_b0110","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cgh.2016.05.046","article-title":"Noninvasive detection of nonalcoholic steatohepatitis using clinical markers and circulating levels of lipids and metabolites","volume":"14","author":"Zhou","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.cca.2021.10.018_b0115","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.3390\/ijms22084156","article-title":"Role of insulin resistance in MAFLD","volume":"22","author":"Sakurai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cca.2021.10.018_b0120","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.cca.2021.10.018_b0125","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.3390\/ijms19072034","article-title":"New aspects of lipotoxicity in nonalcoholic steatohepatitis","volume":"19","author":"Mendez-Sanchez","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2021.10.018_b0130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.cca.2021.10.018_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol Int."},{"issue":"4","key":"10.1016\/j.cca.2021.10.018_b0140","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/nu11040872","article-title":"Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation","volume":"11","author":"Yang","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.cca.2021.10.018_b0145","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cca.2021.10.018_b0150","first-page":"48","article-title":"Pediatric non-alcoholic fatty liver disease","volume":"4","author":"Bush","year":"2017","journal-title":"Children (Basel)."},{"issue":"3","key":"10.1016\/j.cca.2021.10.018_b0155","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.gastro.2015.05.044","article-title":"Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease","volume":"149","author":"du Plessis","year":"2015","journal-title":"Gastroenterology"},{"issue":"17\u201318","key":"10.1016\/j.cca.2021.10.018_b0160","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.clinbiochem.2011.09.017","article-title":"Some inflammatory cytokine levels, iron metabolism and oxidant stress markers in subject with nonalcoholic steatohepatitis","volume":"44","author":"Uysal","year":"2011","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.cca.2021.10.018_b0165","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1053\/j.gastro.2015.12.037","article-title":"Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes","volume":"150","author":"Hirsova","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cca.2021.10.018_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest."},{"issue":"28","key":"10.1016\/j.cca.2021.10.018_b0175","doi-asserted-by":"crossref","first-page":"e21162","DOI":"10.1097\/MD.0000000000021162","article-title":"Correlation between the small dense LDL level and nonalcoholic fatty liver disease: possibility of a new biomarker","volume":"99","author":"Hwang","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2021.10.018_b0180","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00041433-200406000-00014","article-title":"Electronegative low-density lipoprotein","volume":"15","author":"S\u00e1nchez-Quesada","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.cca.2021.10.018_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/181324","article-title":"Electronegative LDL: a circulating modified LDL with a role in inflammation","volume":"2013","author":"Estruch","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cca.2021.10.018_b0190","doi-asserted-by":"crossref","first-page":"109821","DOI":"10.1016\/j.mehy.2020.109821","article-title":"Why are cardiovascular diseases more common among patients with severe mental illness? The potential involvement of electronegative low-density lipoprotein (LDL) L5","volume":"142","author":"Akyol","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"9","key":"10.1016\/j.cca.2021.10.018_b0195","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3390\/jcm10091992","article-title":"Autoimmune rheumatic diseases: An update on the role of atherogenic electronegative LDL and potential therapeutic strategies","volume":"10","author":"Chen","year":"2021","journal-title":"J. Clinical. Med."},{"issue":"10","key":"10.1016\/j.cca.2021.10.018_b0200","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2015-05-646117","article-title":"Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation","volume":"127","author":"Shen","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.cca.2021.10.018_b0205","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1210\/jc.2017-01657","article-title":"Electronegative low-density lipoprotein L5 induces adipose tissue inflammation associated with metabolic syndrome","volume":"102","author":"Ke","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cca.2021.10.018_b0210","doi-asserted-by":"crossref","first-page":"H265","DOI":"10.1152\/ajpheart.00509.2016","article-title":"L5-LDL from ST-elevation myocardial infarction patients induces IL-1\u03b2 production via LOX-1 and NLRP3 inflammasome activation in macrophages","volume":"312","author":"Yang","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"12","key":"10.1016\/j.cca.2021.10.018_b0215","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/biomedicines8120550","article-title":"Molecular and cellular mechanisms of electronegative lipoproteins in cardiovascular diseases","volume":"8","author":"Ke","year":"2020","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.cca.2021.10.018_b0220","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bbalip.2016.05.010","article-title":"Inflammatory intracellular pathways activated by electronegative LDL in monocytes","volume":"1861","author":"Estruch","year":"2016","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids"},{"issue":"8","key":"10.1016\/j.cca.2021.10.018_b0225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/biomedicines8080254","article-title":"Clinical significance of electronegative low-density lipoprotein cholesterol in atherothrombosis","volume":"8","author":"Chu","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2021.10.018_b0230","first-page":"1","article-title":"Electronegative LDL from rabbits fed with atherogenic diet is highly proinflammatory","volume":"2019","author":"Chang","year":"2019","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cca.2021.10.018_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2017.10.016","article-title":"Electronegative L5-LDL induces the production of G-CSF and GM-CSF in human macrophages through LOX-1 involving NF-kappaB and ERK2 activation","volume":"267","author":"Yang","year":"2017","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.cca.2021.10.018_b0240","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","article-title":"Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease","volume":"15","author":"Anstee","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.cca.2021.10.018_b0245","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/CIRCRESAHA.119.316337","article-title":"Non-alcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases","volume":"126","author":"Cai","year":"2020","journal-title":"Circ. Res."},{"issue":"13","key":"10.1016\/j.cca.2021.10.018_b0250","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1042\/CS20200446","article-title":"Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis","volume":"134","author":"Zhang","year":"2020","journal-title":"Clin. Sci. (Lond)."},{"key":"10.1016\/j.cca.2021.10.018_b0255","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fmed.2019.00202","article-title":"Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review","volume":"6","author":"Ismaiel","year":"2019","journal-title":"Front. Med. (Lausanne)."},{"key":"10.1016\/j.cca.2021.10.018_b0260","first-page":"1","article-title":"Hepatocardiac or cardiohepatic interaction: From traditional Chinese medicine to Western medicine","volume":"2021","author":"Zhang","year":"2021","journal-title":"Evi.d Based Complement Alternat Med."},{"issue":"20","key":"10.1016\/j.cca.2021.10.018_b0265","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.12998\/wjcc.v8.i20.4688","article-title":"Relationship between non-alcoholic fatty liver disease and coronary heart disease","volume":"8","author":"Arslan","year":"2020","journal-title":"World J. Clin. Cases."},{"issue":"6","key":"10.1016\/j.cca.2021.10.018_b0270","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/jc.2004-2240","article-title":"Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity","volume":"90","author":"Bugianesi","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.cca.2021.10.018_b0275","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/hep.25539","article-title":"Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease","volume":"55","author":"Lomonaco","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2021.10.018_b0280","doi-asserted-by":"crossref","first-page":"100001","DOI":"10.1194\/jlr.RA120000767","article-title":"Adiponectin forms a complex with atherogenic LDL and inhibits its downstream effects","volume":"62","author":"Kakino","year":"2020","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.cca.2021.10.018_b0285","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties","volume":"178","author":"Moschen","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2021.10.018_b0290","doi-asserted-by":"crossref","DOI":"10.1186\/s12950-019-0211-5","article-title":"Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease","volume":"16","author":"Ho","year":"2019","journal-title":"J. Inflamm."},{"issue":"3","key":"10.1016\/j.cca.2021.10.018_b0295","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/cells9030583","article-title":"Electronegative LDL promotes inflammation and triglyceride accumulation in macrophages","volume":"9","author":"Puig","year":"2020","journal-title":"Cells"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121003624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121003624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:04:59Z","timestamp":1757862299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898121003624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":59,"alternative-id":["S0009898121003624"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2021.10.018","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2021.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}